Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy

PURPOSE: Radiation dose escalation for prostate cancer improves biochemical control but is limited by toxicity. Magnetic resonance spectroscopic imaging (MRSI) can define dominant intraprostatic lesions (DIL). This phase I study evaluated dose escalation to MRSI-defined DIL using high-dose-rate (HDR...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Contemp Brachytherapy
Glavni autori: Chapman, Christopher H, Braunstein, Steve E, Pouliot, Jean, Noworolski, Susan M, Weinberg, Vivian, Cunha, Adam, Kurhanewicz, John, Gottschalk, Alexander R, Roach, Mack III, Hsu, I-Chow
Format: Artigo
Jezik:Inglês
Izdano: Termedia Publishing House 2018
Teme:
Original Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6052382/
https://ncbi.nlm.nih.gov/pubmed/30038638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2018.76881
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items